Article
CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment.
Journal of clinical laboratory analysis - 1 Jun 2018
Hou Xumin, Han Wenzheng, Gan Qian, Liu Yuan, Fang Weiyi
Abstract excerpt
BACKGROUND: This study was aimed to investigate the correlation between CYP2C19 and ABCB1 polymorphisms and the recurrence of ischemic cardiovascular adverse events in patients with coronary artery disease treated with clopidogrel. METHODS: A total of 168 patients with coronary heart disease who underwent PCI operation and received clopidogrel treatment were enrolled. Dual antiplatelet therapy was applied to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
